awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27005445-58D28E81-E9E4-4835-B84D-209F9D74E790
Q27005445-58D28E81-E9E4-4835-B84D-209F9D74E790
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27005445-58D28E81-E9E4-4835-B84D-209F9D74E790
Inflammatory pathways of importance for management of inflammatory bowel disease
P2860
Q27005445-58D28E81-E9E4-4835-B84D-209F9D74E790
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27005445-58D28E81-E9E4-4835-B84D-209F9D74E790
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9c2380545c89050bc2146ee17f7662e3d729a47c
P2860
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.